give protected methyl ester 28 (3.20 g, 94%) as a colourless oil.
Rf [hexane : EtOAc (4 : 1)] 0.60; [α]D Ϫ48.5 (c 1.07, CHCl3);
νmax (neat)/cmϪ1 3062, 3028, 2948, 2855, 1735, 1602, 1494, 1453;
δH (250 MHz, CDCl3) 7.41–7.21 (15H, m, ArH ), 4.52–4.30
(2H, m, OCHEHFPh), 3.96 (2H, d, J 13.9, NCHXHYPh × 2),
3.89 (1H, t, J 2.8, C(2)H ), 3.85–3.79 (1H, m, C(3)HAHB), 3.78
(3H, s, OMe), 3.75–3.68 (1H, m, C(3)HAHB), 3.72 (2H, d,
J 13.9, NCHXHYPh × 2); δC (62.9 MHz) 171.8 (C), 139.5 (C),
137.9 (C), 128.6 (CH), 128.2 (CH), 128.1 (CH), 127.4 (CH),
126.9 (CH), 73.0 (CH2), 69.4 (CH2), 60.8 (CH), 55.2 (CH2), 51.2
(CH3); m/z (FAB) 390 ([M ϩ H]ϩ, 15%), 330 (32), 282 (8), 268
(41), 181 (9), 91 (100); HRMS (FAB) C25H28NO3 [M ϩ H]ϩ
requires 390.2069, found 390.2070.
Ethyl (3SR, 4SR)-5-benzyloxy-4-(N,N-dibenzylamino)-3-
hydroxypentanoate 32
To a solution of β-keto ester 31 (80 mg, 0.18 mmol) in Et2O
(4 cm3) and MeOH (2 cm3) was added acetic acid (ca. 0.5 cm3)
until the solution was pH 4. The solution was cooled to 0 ЊC
and sodium cyanoborohydride (60 mg, 1.4 mmol) was added.
Once effervescence ceased the solution was warmed to room
temperature and stirred for 8 hours. The solution was quenched
by the addition of a saturated solution of NH4Cl (15 cm3) and
the aqueous phase was extracted with DCM (3 × 15 cm3). The
combined organic phases were washed with brine (20 cm3),
dried (MgSO4) and concentrated under reduced pressure. The
residue was chromatographed on silica gel [hexane : EtOAc
(6 : 1)] to give the amino alcohol 32 (72 mg, 90%) as an oil. Rf
[hexane : EtOAc (4 : 1)] 0.38; νmax (neat)/cmϪ1 3371, 2936, 1726,
1452; δH (250 MHz, CDCl3) 7.43–7.19 (15H, m, ArH ), 4.59
(1H, d, J 12.0, OCHEHFPh), 4.52 (1H, d, J 12.0, OCHEHFPh),
4.19 (1H, ddd, J 11.2, 8.5, 3.6, C(3)HOH), 4.14 (2H, q, J 7.2,
OCH2CH3), 4.05 (2H, d, J 13.2, NCHXHYPh × 2), 3.80 (1H, dd,
J 10.2, 5.5, C(5)HAHB), 3.69 (1H, dd, J 10.2, 4.8, C(5)HAHB),
3.53 (2H, d, J 13.2, NCHXHYPh × 2), 3.47 (1H, s, OH ), 2.80–
2.72 (1H, m, C(4)H ), 2.50 (1H, dd, J 15.4, 3.6, C(2)HCHD), 2.37
(1H, dd, J 15.4, 8.5, C(2)HCHD), 1.23 (3H, t, J 7.2, OCH2CH3);
δC (62.9 MHz) 172.0 (C), 138.8 (C), 137.8 (C), 129.0 (CH),
128.4 (CH), 127.7 (CH), 127.5 (CH), 127.1 (CH), 73.2 (CH2),
66.3 (CH2), 65.7 (CH2), 61.3 (CH), 60.4 (CH), 54.3 (CH2), 39.45
(CH2), 14.0 (CH3); m/z (FAB) 448 ([M ϩ H]ϩ, 20%), 330 (19),
326 (5), 210 (2), 181 (4), 91 (100); HRMS (FAB) C28H34NO4
[M ϩ H]ϩ requires 448.2488, found 448.2489.
(2SR)-2-(N,N-Dibenzylamino)-3-benzyloxypropanoic acid 29
To a solution of the ester 28 (300 mg, 0.771 mmol) in THF
(8 cm3) was added a slurry of LiOHؒH2O (194 mg, 4.63 mmol)
in H2O (2 cm3). The mixture was heated to reflux and held
at reflux for 4 hours. The solution was cooled to room tempera-
ture, water (15 cm3) was added and the mixture was acidified
to pH 3 with 1 M HCl. The aqueous phase was extracted
with Et2O (3 × 15 cm3). The combined organic phases were
dried (MgSO4) and concentrated under reduced pressure to give
acid 29 (288 mg, 100%). Rf [hexane : EtOAc (4 : 1)] 0.13; νmax
(neat)/cmϪ1 4059, 3067, 3028, 2923, 2854, 1715, 1495; δH (250
MHz, CDCl3) 7.67–7.03 (15H, m, ArH ), 4.63 (1H, d, J 11.9,
OCHEHFPh), 4.55 (1H, d, J 11.9, OCHEHFPh), 4.17 (1H, dd,
J 10.3, 4.6, C(3)HAHB), 4.06 (2H, d, J 13.3, NCHXHYPh × 2),
4.01–3.67 (2H, m, C(3)HAHB ϩ C(2)H ), 3.94 (2H, d, J 13.3,
NCHXHYPh × 2); δC (62.9 MHz) 171.1 (C), 137.5 (C), 135.8
(C), 129.2 (CH), 128.7 (CH), 128.4 (CH), 128.1 (CH), 127.8
(CH), 127.2 (CH), 73.4 (CH2), 67.5 (CH2), 61.5 (CH), 55.1
(CH2); m/z (FAB) 376 ([M ϩ H]ϩ, 100%), 330 (16), 286 (31), 240
(12) 181 (20), 91 (91); HRMS (FAB) C24H26NO3 [M ϩ H]ϩ
requires 376.1913, found 376.1914.
Acknowledgements
We thank the EPSRC (GR/L60166/01 to K.S.C.) for support.
References
Ethyl (4SR)-5-benzyloxy-4-(N,N-dibenzylamino)-3-oxo-
1 R. J. Nash, A. E. Bell, G. W. J. Fleet, R. H. Jones and M. J. Williams,
J. Chem. Soc., Chem. Commun., 1985, 738.
pentanoate 31
To a solution of acid 29 (300 mg, 0.825 mmol) in THF (8 cm3)
was added 1,1Ј-carbonyldiimidazole (404 mg, 2.49 mmol).
The solution was stirred at room temperature for 2 hours to
generate imidazolide 30. Meanwhile to a solution of LiHMDS
(2.49 cm3, 1.0 M in THF, 2.49 mmol) at Ϫ78 ЊC was added ethyl
acetate (0.240 cm3, 2.49 mmol) and the solution stirred for
20 min. The solution of imidazolide 30 in THF was added via
cannula and the solution stirred at Ϫ78 ЊC for 30 min then
warmed to 0 ЊC over a period of 1 hour. The mixture was stirred
at 0 ЊC for 1 hour before being quenched with saturated
aqueous NH4Cl (20 cm3). The aqueous phase was extracted
with DCM (3 × 20 cm3). The combined organic phases were
washed with brine (30 cm3), dried (MgSO4) and concentrated
under reduced pressure. The residue was chromatographed on
silica gel [hexane : EtOAc (10 : 1)] to give the β-keto ester 31
(340 mg, 92%) as a pale yellow oil. Rf [hexane : EtOAc (4 : 1)]
0.53; νmax (neat)/cmϪ1 3062, 3029, 2081, 2926, 2860, 1744,
1716, 1494, 1453; δH (250 MHz, CDCl3) 7.43–7.22 (15H, m,
ArH ), 4.62 (1H, d, J 12.0, OCHEHFPh), 4.55 (1H, d, J 12.0,
OCHEHFPh), 4.14 (2H, q, J 7.2, OCH2CH3), 4.01 (1H, dd,
J 9.2, 6.5, C(5)HAHB), 3.94 (1H, dd, J 9.2, 4.0, C(5)HAHB), 3.85
(2H, d, J 13.1, NCHXHYPh × 2), 3.75–3.65 (1H, m, C(4)H ),
3.73 (1H, d, J 16.0, C(2)HCHD), 3.70 (2H, d, J 13.1, NC-
HXHYPh × 2), 3.54 (1H, d, J 16.0, C(2)HCHD), 1.23 (3H, t,
J 7.2, OCH2CH3); δC (62.9 MHz) 202.7 (C), 167.3 (C), 138.9
(C), 137.9 (C), 128.9 (CH), 128.5 (CH), 128.3 (CH), 127.5 (CH),
127.1 (CH), 126.8 (CH), 73.4 (CH2), 66.1 (CH), 65.4 (CH2),
61.0 (CH2), 55.0 (CH2), 46.5 (CH2), 13.9 (CH3); m/z (FAB) 446
([M ϩ H]ϩ, 100%), 356 (39), 330 (53), 240 (22), 196 (17), 132 (9),
106 (37), 91 (97); HRMS (FAB) C28H32NO4 [M ϩ H]ϩ requires
446.2331, found 446.2332.
2 L. D. Hohenschutz, E. A. Bell, P. J. Jewess, D. P. Leworthy,
R. J. Pryce, E. Arnold and J. Clardy, Phytochemistry, 1981, 20, 811.
3 A. M. Schofield, P. Witham, R. J. Nash, G. C. Kite and
L. E. Fellows, Comp. Biochem. Physiol., 1995, 112A, 187.
4 A. M. Schofield, L. E. Fellows, R. J. Nash and G. W. J. Fleet, Life
Sci., 1986, 39, 645.
5 (a) J. Furukawa, S. Okuda, K. Saito and S.-I. Hatanaka,
Phytochemistry, 1985, 24, 593; (b) R. J. Nash, E. A. Bell and
J. M. Williams, Phytochemistry, 1985, 24, 1620.
6 (a) A. D. Elbein, M. Mitchell, B. A. Stanford, L. E. Fellows and
S. V. Evans, J. Biol. Chem., 1984, 259, 12409; (b) S. V. Evans,
L. E. Fellows and E. A. Bell, Biochem. Syst. Ecol., 1985, 13, 271;
(c) A. Welter, J. Jadot, G. Dardenne, M. Marlier and J. Casimir,
Phytochemistry, 1976, 15, 747; (d ) absolute stereochemistry:
G. W. Fleet and P. W. Smith, Tetrahedron, 1987, 43, 971.
7 N. Dell’Uomo, M. C. DiGiovanni, D. Misiti, G. Zappia and
G. Delle Monache, Tetrahedron: Asymmetry, 1996, 7, 181.
8 N-Hydroxyethyl derivative of CYB-3 as biosynthetic precursor
for castanospermine and australine: R. J. Molyneux, Y. T. Pan,
J. E. Tropea, M. Benson, G. P. Kaushal and A. D. Elbein,
Biochemistry, 1991, 30, 9981.
9 G. Ceulemans, A. Van Aerschot, J. Rozenski and P. Herdewijn,
Tetrahedron, 1997, 53, 14957.
10 (a) Reaction with (allyl)B(Ipc)2: L. M. Mascavage, Q. Lu, J. Vey,
D. R. Dalton and P. J. Carroll, J. Org. Chem., 2001, 66, 3621; (b)
reaction with allyl bromide/CrCl2: Y Aoyagi, H. Inaba, Y. Hiraiwa,
A. Kuroda and A. Ohta, J. Chem. Soc., Perkin Trans. 1, 1998, 3975.
11 A. Barco, S. Benetti, C. De Risi, G. P. Pollini, R. Romagnoli and
V. Zanirato, Tetrahedron Lett., 1996, 37, 7599.
12 (a) C. Herdeis, H. P. Hubmann and H. Lotter, Tetrahedron:
Asymmetry, 1994, 5, 119; (b) D. Griffart-Brunet and N. Langlois,
Tetrahedron Lett., 1994, 35, 119.
13 (a) B. M. Malle, I. Lundt and R. H. Furneaux, J. Carbohydr. Chem.,
2000, 19, 573; (b) A. G. H. Wee, D. D. McLeod and T. J. Rankin,
Heterocycles, 1998, 48, 2263.
14 C. M. Huwe and S. Blechert, Synthesis, 1997, 61.
1090
J. Chem. Soc., Perkin Trans. 1, 2002, 1083–1091